NCT03908931 Descriptive Study of the Reconstruction of Osteochondral Lesions of the Knee: Clinical and Imaging Results
| NCT ID | NCT03908931 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Versailles Hospital |
| Condition | Osteochondral Defect |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2019-04-01 |
| Primary Completion | 2019-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2019-04-01 with a primary completion date of 2019-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the clinical results and MRI imaging of autologous cartilage reconstructions or collagen matrix of the knee. There is currently little data in the literature on clinical outcomes and imaging of this type of lesion.
Eligibility Criteria
Inclusion Criteria: * cartilaginous reconstruction by autologous transplant or collagenous chondro-inducing knee matrix * \> 18 years Exclusion Criteria: * Other cartilaginous reconstruction techniques, * other than knee joint
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03908931 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteochondral Defect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03908931 currently recruiting?
Yes, NCT03908931 is actively recruiting participants. Contact the research team at npujol@ch-versailles.fr for enrollment information.
Where is the NCT03908931 trial being conducted?
This trial is being conducted at Le Chesnay, France.
Who is sponsoring the NCT03908931 clinical trial?
NCT03908931 is sponsored by Versailles Hospital. The trial plans to enroll 130 participants.